mRNA Therapeutics Market Report 2024-2030: A Projected $31.3 Billion Opportunity Dominated by Moderna, BioNTech, and CureVac
May 29, 2024 06:59 ET
|
Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The global mRNA...
Cellectis Reports Financial Results for First Quarter 2024
May 28, 2024 16:30 ET
|
Cellectis Inc.
• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca • Cash position of $143 million as of March 31, 20241; cash runway projection into 20262 • Conference...
Cellectis publie ses résultats financiers du premier trimestre 2024
May 28, 2024 16:30 ET
|
Cellectis Inc.
• Cellectis annonce la réalisation de l’investissement additionnel d’AstraZeneca • Situation de trésorerie de 143 millions de dollars au 31 mars 20241, projection de la trésorerie jusqu’en 20262...
World Immuno-Oncology Diagnostics Market Forecasts Report 2024: The Disruption Dynamic, The Race for Biomarkers, The Next Five Years
May 28, 2024 09:06 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis" report has been added to ...
Global Topical Wound Agents Market Size To Exceed USD 3.7 Billion By 2033 | CAGR Of 6.89%
May 25, 2024 16:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , May 25, 2024 (GLOBE NEWSWIRE) -- The Global Topical Wound Agents Market Size to Grow from USD 1.9 Billion in 2023 to USD 3.7 Billion by 2033, at a Compound Annual...
Global Diabetes Drug Analysis Report 2024: A $107.02 Billion Market by 2032 Driven by Novo Nordisk, AstraZeneca, Biocon, Sanofi, Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, Novartis
May 24, 2024 07:07 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetes Drug Market Report by Drug class, Diabetes types, Route of Administration, Distribution Channels, Region and Company Analysis 2024-2032"...
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
May 23, 2024 08:00 ET
|
CRISPR Therapeutics AG
-Naimish Patel, M.D., appointed to Chief Medical Officer- -Julianne Bruno, M.B.A., promoted to Chief Operating Officer- ZUG, Switzerland and BOSTON, May 23, 2024 (GLOBE NEWSWIRE) --...
Fc and Glycoengineered Antibodies Research 2024: Market Experiences Over 30% Growth in Collaborations in Past Two Years, Fueled by Strategic Partnerships - Long-term Forecasts to 2035
May 22, 2024 04:47 ET
|
Research and Markets
Dublin, May 22, 2024 (GLOBE NEWSWIRE) -- The "Fc and Glycoengineered Antibodies Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Engineering, Type of Therapy,...
Severs Disease Treatment Market Size to Worth USD 1.87 Bn By 2031
May 21, 2024 11:41 ET
|
CMI
Burlingame, May 21, 2024 (GLOBE NEWSWIRE) -- The global Sever's Disease Treatment Market is projected to grow from USD 1.34 billion in 2024, and it is projected to reach USD 1.87 billion by 2031, at...
Global Retinoblastoma Treatment Market Size To Exceed USD 3.8 Billion By 2033 | CAGR of 4.28%
May 21, 2024 10:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, May 21, 2024 (GLOBE NEWSWIRE) -- The Global Retinoblastoma Treatment Market Size is to Grow from USD 2.5 Billion in 2023 to USD 3.8 Billion by 2033, at a Compound Annual...